Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-25

Clinical Trial Update: Relapses in Plasmodium Ovale and Efficacy of Artemether-lumefantrine for Mixed Species and Non-falciparum Malaria [NA]

View source ↗

Summary

This trial update notes relapses in Plasmodium ovale and evaluates the efficacy of artemether-lumefantrine for mixed-species and non-falciparum malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemether-lumefantrine (artemether and lumefantrine)

Snippet

Sponsor: Albert Schweitzer Hospital | Conditions: Malaria | NA | Status: COMPLETED